BCM
INSM icon

Brookstone Capital Management’s Insmed INSM Stock Holding History

Brookstone Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-325
Closed -$6K – 505
2015
Q3 		$6K Hold
325
– – ﹤0.01% 1341
2015
Q2 		$8K Buy
+325
New +$7.38K ﹤0.01% 1335

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Brookstone Capital Management's INSM Position: Q4 2015 in Review

Brookstone Capital Management sold out of Insmed (INSM) in Q4 2015, closing a stake of 325 shares — an estimated $6K sold.

Brookstone Capital Management first reported a position in INSM in Q2 2015 and held it in 2 quarters. The position peaked at $8K in Q2 2015. 114 funds tracked by Wall St. Rank hold INSM as of Q4 2015.

  • Brookstone Capital Management reported no remaining Insmed position as of Q4 2015 after selling out during the quarter.
  • Brookstone Capital Management sold 325 Insmed shares in Q4 2015, an estimated $6K.
  • Brookstone Capital Management first reported a position in Insmed in Q2 2015 and held it in 2 quarters.
  • Brookstone Capital Management's Insmed position peaked at $8K in Q2 2015.
  • 114 funds tracked by Wall St. Rank held Insmed as of Q4 2015.

Based on Brookstone Capital Management's 13F filing for Q4 2015, filed 14 Jan 2016.